TY  - JOUR
AU  - Sarno, Federica
AU  - Papulino, Chiara
AU  - Franci, Gianluigi
AU  - Andersen, Jeanette H
AU  - Cautain, Bastien
AU  - Melardo, Colombina
AU  - Altucci, Lucia
AU  - Nebbioso, Angela
PY  - 2018
DO  - 10.3389/fphar.2018.01006
SN  - 1663-9812
UR  - http://hdl.handle.net/10668/12986
T2  - Frontiers in pharmacology
AB  - Despite the discovery and development of novel therapies, cancer is still a leading cause of death worldwide. In order to grow, tumor cells require large quantities of nutrients involved in metabolic processes, and an increase in iron levels is known...
LA  - en
KW  - cancer
KW  - chromatin remodeling
KW  - epigenetics
KW  - iron chelating agent
KW  - novel therapies
TI  - 3-Chloro-N'-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy.
TY  - research article
VL  - 9
ER  -